Dog /
FDA CVM · 2025 release 63 reports on file

Terrier - Bedlington - FDA Adverse Event Profile

Adverse-event records for Terrier - Bedlington (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 13 9.75 6.5 3.25 0 2016 2017 2018 2019 2020 2022 2023 2025 Reports filed Death-coded reports
Annual report volume for Terrier - Bedlington drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

Terrier - Bedlington ranks #259 by report volume among dog breeds - 5 of 63 reports (7.9%) recorded a death outcome.

#259
most-reported dog breed
7.9%
death-coded report share
10
Vomiting - top reaction
7.0 yr
average age at report

Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.

Total Reports

63

FDA CVM filings

Deaths Reported

5

of 63 reports

Death Rate

7.9%

death-coded share

Avg Age at Report

7.0 yr

9.1 kg avg weight

Death-Coded Outcome Share

Terrier - Bedlington death-coded reports 7.9%
Cross-breed median

7.9% of 63 terrier - bedlington reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 9.1 kg (20.1 lbs)

Top Reported Reactions

Vomiting 10
Emesis 8
Lethargy (see also Central nervous system depression in 'Neurological') 8
Seizure NOS 7
Anorexia 6

Most Referenced Drugs

Milbemycin Oxime + Spinosad 9
Fluralaner Chew Tablets 8
Spinosad 7
Nitenpyram 4
Oclacitinib Maleate 4

Outcome Breakdown

Recovered/Normal
24 (40.7%)
Outcome Unknown
15 (25.4%)
Ongoing
13 (22.0%)
Euthanized
3 (5.1%)
Died
2 (3.4%)
Recovered with Sequela
2 (3.4%)

Gender Distribution

Female 33 (52.4%)
Male 30 (47.6%)

Reports by Year

Year Reports Trend
2010 2
2011 5
2012 6
2013 6
2014 1
2015 6
2016 8
2017 13
2018 4
2019 5
2020 4
2022 1
2023 1
2025 1

Terrier - Bedlington Pet Health Insights

Terrier - Bedlington accounts for 63 FDA adverse event reports, ranking #259 by volume among dog breeds, with 5 reports (7.9%) coded as a death outcome. Mean age at report: 7.0 years, average weight 9.1 kg (20.1 lbs).

Top reported signs: Vomiting (10), Emesis (8), Lethargy (see also Central nervous system depression in 'Neurological') (8). Most-referenced drug: Milbemycin Oxime + Spinosad (9 reports), followed by Fluralaner Chew Tablets (8) and Spinosad (7).

Outcome coding on 59 status-recorded reports is dominated by Recovered/Normal (40.7%). Annual submissions ranged 2,010-2,025 across 14 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Terrier - Bedlington?
There are 63 adverse event reports involving Terrier - Bedlington in the FDA database, with 5 reports involving death (7.9% death rate). Terrier - Bedlington ranks #259 by report volume.
What are the most common adverse reactions reported for Terrier - Bedlington?
The most commonly reported adverse reactions for Terrier - Bedlington are Vomiting (10 reports), Emesis (8 reports), Lethargy (see also Central nervous system depression in 'Neurological') (8 reports), Seizure NOS (7 reports), Anorexia (6 reports).
What drugs are most frequently associated with Terrier - Bedlington adverse events?
The drugs most frequently referenced in Terrier - Bedlington adverse event reports are Milbemycin Oxime + Spinosad (9 reports), Fluralaner Chew Tablets (8 reports), Spinosad (7 reports), Nitenpyram (4 reports), Oclacitinib Maleate (4 reports).
What is the average age of Terrier - Bedlington in adverse event reports?
The average age of Terrier - Bedlington at the time of adverse event reports is 7.0 years, with an average weight of 9.1 kg (20.1 lbs).
Does a high number of adverse event reports mean Terrier - Bedlington is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Terrier - Bedlington safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.